98 related articles for article (PubMed ID: 11829795)
21. P53 mutations in primary and metastatic tumors and circulating tumor cells from colorectal carcinoma patients.
Khan ZA; Jonas SK; Le-Marer N; Patel H; Wharton RQ; Tarragona A; Ivison A; Allen-Mersh TG
Clin Cancer Res; 2000 Sep; 6(9):3499-504. PubMed ID: 10999735
[TBL] [Abstract][Full Text] [Related]
22. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
[TBL] [Abstract][Full Text] [Related]
23. Influence of FasL gene expression on hepatic metastasis of colorectal carcinoma.
Li SY; Yu B; An P; Wei JC; Zuo FY; Cai HY
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):226-9. PubMed ID: 15138115
[TBL] [Abstract][Full Text] [Related]
24. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M
Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277
[TBL] [Abstract][Full Text] [Related]
25. Noninvasive detection through REMS-PCR technique of K-ras mutations in stool DNA of patients with colorectal cancer.
Mixich F; Ioana M; Voinea F; Săftoiu A; Ciurea T
J Gastrointestin Liver Dis; 2007 Mar; 16(1):5-10. PubMed ID: 17410282
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Ki-ras gene mutations within the same tumor using a single tumor crypt in colorectal carcinomas.
Ishii M; Sugai T; Habano W; Nakamura S
J Gastroenterol; 2004 Jun; 39(6):544-9. PubMed ID: 15235871
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
Fujii S; Fujimori T; Chiba T
J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
[TBL] [Abstract][Full Text] [Related]
28. Alterations of the K-ras and p53 genes and microsatellite instability in sporadic colorectal carcinomas.
Hasegawa A; Fukushima T; Mashiko M; Nakano K; Suzuki S; Endo Y; Ohki S; Hatakeyama Y; Koyama Y; Inoue N; Takebayashi Y; Sekikawa K; Takenoshita S
Anticancer Res; 2004; 24(3b):2047-52. PubMed ID: 15274399
[TBL] [Abstract][Full Text] [Related]
29. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S
Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160
[TBL] [Abstract][Full Text] [Related]
30. K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Zhi LZ; Miura H; Ochiai M; Funabiki T
J Hepatobiliary Pancreat Surg; 2002; 9(3):312-21. PubMed ID: 12353142
[TBL] [Abstract][Full Text] [Related]
31. Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors.
Khanna M; Park P; Zirvi M; Cao W; Picon A; Day J; Paty P; Barany F
Oncogene; 1999 Jan; 18(1):27-38. PubMed ID: 9926917
[TBL] [Abstract][Full Text] [Related]
32. Harmonized microarray/mutation scanning analysis of TP53 mutations in undissected colorectal tumors.
Favis R; Huang J; Gerry NP; Culliford A; Paty P; Soussi T; Barany F
Hum Mutat; 2004 Jul; 24(1):63-75. PubMed ID: 15221790
[TBL] [Abstract][Full Text] [Related]
33. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
Mahdavinia M; Bishehsari F; Verginelli F; Cumashi A; Lattanzio R; Sotoudeh M; Ansari R; Semeraro D; Hormazdi M; Fakheri H; Rakhshani N; De Lellis L; Curia MC; Cama A; Piantelli M; Malekzadeh R; Iacobelli S; Mariani-Costantini R
J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889
[TBL] [Abstract][Full Text] [Related]
34. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
Nindl I; Gottschling M; Krawtchenko N; Lehmann MD; Röwert-Huber J; Eberle J; Stockfleth E; Forschner T
Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
[TBL] [Abstract][Full Text] [Related]
35. [Detection of K-ras mutations in colon cancer by PHA-PHFA (preferential homoduplex formation assay)].
Funato T; Zeng Z; Satoh J; Fujiwara J; Kaku M; Sasaki T
Rinsho Byori; 1999 Nov; 47(11):1059-63. PubMed ID: 10590684
[TBL] [Abstract][Full Text] [Related]
36. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
[TBL] [Abstract][Full Text] [Related]
37. Approaching real-time molecular diagnostics: single-pair fluorescence resonance energy transfer (spFRET) detection for the analysis of low abundant point mutations in K-ras oncogenes.
Wabuyele MB; Farquar H; Stryjewski W; Hammer RP; Soper SA; Cheng YW; Barany F
J Am Chem Soc; 2003 Jun; 125(23):6937-45. PubMed ID: 12783546
[TBL] [Abstract][Full Text] [Related]
38. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
39. [Detection of genetic mutations in clinical specimens from cancer patients: comparison of NIRCA and SSCP scanning methods].
Botezatu IV; Kondratova VN; Cherkes VL; Barsukov IuA; Aliev VE; Shelepov VP; Likhtenshteĭn AV
Vopr Onkol; 2007; 53(5):549-53. PubMed ID: 18154119
[TBL] [Abstract][Full Text] [Related]
40. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
Mueller J; Gansauge S; Mattfeldt T
Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]